MENU
+Compare
INSM
Stock ticker: NASDAQ
AS OF
Dec 26, 04:59 PM (EDT)
Price
$177.86
Change
+$0.44 (+0.25%)
Capitalization
37.84B

INSM Insmed Forecast, Technical & Fundamental Analysis

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases... Show more

Industry: #Biotechnology
INSM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for INSM with price predictions
Dec 24, 2025

INSM in upward trend: price may ascend as a result of having broken its lower Bollinger Band on December 18, 2025

INSM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 43 cases where INSM's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INSM's RSI Oscillator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where INSM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where INSM advanced for three days, in of 302 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 212 cases where INSM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on December 08, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on INSM as a result. In of 101 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for INSM turned negative on December 02, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

INSM moved below its 50-day moving average on December 18, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for INSM crossed bearishly below the 50-day moving average on December 23, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INSM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. INSM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (40.000) is normal, around the industry mean (26.541). P/E Ratio (0.000) is within average values for comparable stocks, (51.479). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.873). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (75.758) is also within normal values, averaging (311.015).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
INSM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

INSM is expected to report earnings to fall 26.86% to -127 cents per share on February 19

Insmed INSM Stock Earnings Reports
Q4'25
Est.
$-1.28
Q3'25
Missed
by $0.41
Q2'25
Missed
by $0.40
Q1'25
Missed
by $0.07
Q4'24
Missed
by $0.14
The last earnings report on October 30 showed earnings per share of -175 cents, missing the estimate of -134 cents. With 434.35K shares outstanding, the current market capitalization sits at 37.84B.
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 US Highway 202/206
Phone
+1 908 977-9900
Employees
912
Web
https://www.insmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TECL123.710.97
+0.79%
Direxion Daily Technology Bull 3X ETF
ERH11.770.03
+0.27%
Allspring Utilities and High Income Fund
ETB15.340.04
+0.26%
Eaton Vance Tax-Managed Buy-Write Income Fund
AAPX30.890.07
+0.23%
T-Rex 2X Long Apple Daily Target ETF
TCAL23.80N/A
N/A
T. Rowe Price Capital Appreciation Premium Income ETF

INSM and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, INSM has been closely correlated with THAR. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if INSM jumps, then THAR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.37%
THAR - INSM
74%
Closely correlated
+4.49%
ROIV - INSM
43%
Loosely correlated
+0.22%
AXON - INSM
40%
Loosely correlated
+0.02%
ARRY - INSM
40%
Loosely correlated
+2.10%
FGEN - INSM
39%
Loosely correlated
+1.84%
More

Groups containing INSM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INSM
1D Price
Change %
INSM100%
+0.37%
INSM
(2 stocks)
100%
Closely correlated
+0.71%